In the context of IBD, CAD, an enzyme required for de novo pyrimidine nucleotide synthesis; was identified as a NOD2-interacting protein expressed at increased levels in the colon epithelium of patients with CD compared with controls [36]. Here, NOD2 is linked to inflammatory bowel disease.